Vaginally Administered Danazol: An Overlooked Option in the Treatment of Rectovaginal Endometriosis?
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Danazol has been used in the treatment of endometriosis and heavy menstrual bleeding for more than 40 years. This medication has both central antigonadotropic actions and direct atrophic effects on endometriotic tissue. Although it demonstrates a high-efficacy profile, the associated side effects have resulted in limited usage. Vaginal administration of the drug may prove favourable specifically in rectovaginal endometriosis. This targeted mode of delivery is associated with a significant reduction in both pain symptoms and nodule size. The relative persistence of these therapeutic benefits is likely related to the direct tissue effects after absorption through the vaginal mucosa. Vaginal administration would also limit systemic propagation of danazol and thus should minimize androgenic side effects. Use of vaginal danazol also improves heavy menstrual bleeding and may even restore fertility in some patients. In this review we provide a critical analysis of the existing literature on the use of vaginal danazol.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Good efficacy and better tolerability has been reported with danazol-loaded intrauterine device [221] and with off-label vaginal administration (200 mg/day) [222, 223], particularly for women with DIE and rectovaginal endometriosis [224].”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [224]
Citations
Cites
Clinical Studies with an Antigonadotropin-Danazol
Greenblatt, R. B., Dmowski, W. P., Mahesh, V. B., & Scholer, H. F. L. (1971) · Fertility and Sterility · doi:10.1016/s0015-0282(16)38045-1 · Cited by 219
Danazol for pelvic pain associated with endometriosis
Farquhar, C., Prentice, A., Singla, A. A., & Selak, V. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000068.pub2 · Cited by 210
Danazol: Endocrine pharmacology and therapeutic applications
Barbieri, R. L., & Ryan, K. J. (1981) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(81)90611-6 · Cited by 208
Gonadotrophin-releasing hormone analogues for pain associated with endometriosis
Veth, V. B., van de Kar, M. M., McDonnell, R., Julania, S., & Hart, R. J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008475.pub2 · Cited by 182
Gonadotrophin-releasing hormone analogues for pain associated with endometriosis
Brown, J., Pan, A., & Hart, R. J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008475 · Cited by 172
Abbas, S., Ihle, P., Köster, I., & Schubert, I. (2012) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2011.09.041 · Cited by 164
Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis
Razzi, S., Luisi, S., Calonaci, F., Altomare, A., Bocchi, C., & Petraglia, F. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.12.077 · Cited by 100
Novel conservative medical therapy for uterine adenomyosis with a danazol-loaded intrauterine device
Igarashi, M., Abe, Y., Fukuda, M., Ando, A., 宮坂, 牧., Yoshida, M., & Shawki, O. A. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(00)00624-5 · Cited by 87
Igarashi, M., Iizuka, M., Abe, Y., & Ibuki, Y. (1998) · Human Reproduction · doi:10.1093/humrep/13.7.1952 · Cited by 73
The effects of fetal exposure to danazol
Brunskill, P. J. (1992) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1992.tb14501.x · Cited by 72
Research works printed but not linked: 1
- Takeda, 1994, Local injection of danazol in the treatment of pelvic endometriosis, Asian Med J, 37, 444
Cited by
Hormonal treatments for endometriosis: The endocrine background
Vannuccini, S., Clemenza, S., Rossi, M., & Petraglia, F. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09666-w · Cited by 336
Treatment of endometriosis: a review with comparison of 8 guidelines
Kalaitzopoulos, D. R., Samartzis, N., Kolovos, G. N., Mareti, E., Samartzis, E. P., Eberhard, M., Dinas, K., & Daniilidis, A. (2021) · BMC Women's Health · doi:10.1186/s12905-021-01545-5 · Cited by 209
“Because of the hyperandrogenic side effects (weight gain, acne, hirsutisms, breast atrophy and virilisation), low dose vaginal administration has been proposed [49].”
BackgroundEndometriosis and pain in the adolescent- striking early to limit suffering: A narrative review
Sieberg, C. B., Lunde, C. E., & Borsook, D. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.12.004 · Cited by 66
Role of medical therapy in the management of deep rectovaginal endometriosis
Vercellini, P., Buggio, L., & Somigliana, E. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.08.038 · Cited by 62
The role of pharmacotherapy in the treatment of endometriosis across the lifespan
Schwartz, K. M., Llarena, N. C., Rehmer, J. M., Richards, E. G., & Falcone, T. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1738386 · Cited by 60
“Vaginally administered danazol is thought to have minimal to no systemic absorption and therefore minimal side effects [48].”
BackgroundResult
Metadata
- Authors
- Godin, R., & Marcoux, V.
- Affiliations
- McGill University (CA)
- ORCID
- Godin, Richard
- Venue
- Journal of Obstetrics and Gynaecology Canada
- Publisher
- Elsevier BV
- Published
- 2015-12
- Volume
- 37
- Issue
- 12
- Pages
- 1098-1103
- ISSN
- 1701-2163 (ISSN-L)
- OpenAlex
- W2288794406
- Cited by
- 30
- References
- 32
- Citations by year
- 2026: 5 · 2025: 1 · 2024: 2 · 2022: 5 · 2021: 4 · 2020: 4 · 2019: 4 · 2017: 5
- FWCI
- 0.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Journal of Obstetrics and Gynaecology Canada (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
- Keywords
- danazol, vaginal administration, rectovaginal endometriosis, endometriosis treatment, antigonadotropic effect, androgenic side effects, menorrhagia, fertility restoration
- MeSH terms
- Administration, Intravaginal, Danazol, Endometriosis, Estrogen Antagonists, Female, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vaginally Administered Danazol: An Overlooked Option in the Treatment of Rectovaginal Endometriosis? https://app.cochat.ai/papers/10.1016/s1701-2163(16)30075-5
- The paper
- Godin, R., & Marcoux, V. (2015). Vaginally Administered Danazol: An Overlooked Option in the Treatment of Rectovaginal Endometriosis? Journal of Obstetrics and Gynaecology Canada. https://doi.org/10.1016/s1701-2163(16)30075-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.